{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:55:35Z","timestamp":1791251735099,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,2]]},"DOI":"10.7759\/cureus.93731","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:49:39Z","timestamp":1759438179000},"source":"Crossref","is-referenced-by-count":1,"title":["Immunohistochemical Expression of p16, p53, BCL2, and Cyclin D1 in Gastrointestinal Stromal Tumors: Correlation With Clinicopathological Parameters"],"prefix":"10.7759","author":[{"given":"Marwa M","family":"Zaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman T","family":"Enan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Hany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2018.08.20","article-title":"Gastrointestinal stromal tumors: a comprehensive review","volume":"10","author":"Parab TM","year":"2019","unstructured":"Parab TM, DeRogatis MJ, Boaz AM, et al.. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019, 10:144-54. 10.21037\/jgo.2018.08.20","journal-title":"J Gastrointest Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.872202","article-title":"p53 as a biomarker and potential target in gastrointestinal stromal tumors","volume":"12","author":"Wu CE","year":"2022","unstructured":"Wu CE, Chen CP, Huang WK, Pan YR, Aptullahoglu E, Yeh CN, Lunec J. p53 as a biomarker and potential target in gastrointestinal stromal tumors. Front Oncol. 2022, 12:872202. 10.3389\/fonc.2022.872202","journal-title":"Front Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100812","article-title":"Prognostic indicators for gastrointestinal stromal tumors: a review","volume":"13","author":"Zhang H","year":"2020","unstructured":"Zhang H, Liu Q. Prognostic indicators for gastrointestinal stromal tumors: a review. Transl Oncol. 2020, 13:100812. 10.1016\/j.tranon.2020.100812","journal-title":"Transl Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153689","article-title":"Gastrointestinal stromal tumors (GIST): a population-based study using the SEER database, including management and recent advances in targeted therapy","volume":"14","author":"Khan J","year":"2022","unstructured":"Khan J, Ullah A, Waheed A, et al.. Gastrointestinal stromal tumors (GIST): a population-based study using the SEER database, including management and recent advances in targeted therapy. Cancers (Basel). 2022, 14:9. 10.3390\/cancers14153689","journal-title":"Cancers (Basel)"},{"key":"ref5","article-title":"Expression of p16 predicts poor outcome for patients with gastrointestinal stromal tumors","volume":"10","author":"Jang NR","year":"2017","unstructured":"Jang NR, Choi JH, Gu MJ. Expression of p16 predicts poor outcome for patients with gastrointestinal stromal tumors. Int J Clin Exp Pathol. 2017, 10:6912-7.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-024-00168-y","article-title":"The paradox of senescent-marker positive cancer cells: challenges and opportunities","volume":"10","author":"O'Sullivan EA","year":"2024","unstructured":"O'Sullivan EA, Wallis R, Mossa F, Bishop CL. The paradox of senescent-marker positive cancer cells: challenges and opportunities. NPJ Aging. 2024, 10:41. 10.1038\/s41514-024-00168-y","journal-title":"NPJ Aging"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-3297","article-title":"Cell cycle\/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors","volume":"15","author":"Romeo S","year":"2009","unstructured":"Romeo S, Debiec-Rychter M, Van Glabbeke M, et al.. Cell cycle\/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors. Clin Cancer Res. 2009, 15:4191-8. 10.1158\/1078-0432.CCR-08-3297","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2002898117","article-title":"A negative reciprocal regulatory axis between cyclin D1 and HNF4\u03b1 modulates cell cycle progression and metabolism in the liver","volume":"117","author":"Wu H","year":"2020","unstructured":"Wu H, Reizel T, Wang YJ, et al.. A negative reciprocal regulatory axis between cyclin D1 and HNF4\u03b1 modulates cell cycle progression and metabolism in the liver. Proc Natl Acad Sci U S A. 2020, 117:17177-86. 10.1073\/pnas.2002898117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0894-3","article-title":"Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence","volume":"38","author":"Ou WB","year":"2019","unstructured":"Ou WB, Ni N, Zuo R, et al.. Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence. Oncogene. 2019, 38:6615-29. 10.1038\/s41388-019-0894-3","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.686874","article-title":"Proteasome inhibition suppresses KIT-independent gastrointestinal stromal tumors via targeting Hippo\/YAP\/cyclin D1 signaling","volume":"12","author":"Chen T","year":"2021","unstructured":"Chen T, Ni N, Yuan L, et al.. Proteasome inhibition suppresses KIT-independent gastrointestinal stromal tumors via targeting Hippo\/YAP\/cyclin D1 signaling. Front Pharmacol. 2021, 12:4. 10.3389\/fphar.2021.686874","journal-title":"Front Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal ID","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al.. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020, 76:182-8. 10.1111\/his.13975","journal-title":"Histopathology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.14739\/2310-1237.2021.2.233425","article-title":"Immunohistochemical features of gastrointestinal stromal tumors and the role of expression of p16ink4A, Ki-67, VEGF and MMP-9 in their behavior","volume":"18","author":"Yakovtsova II","year":"2021","unstructured":"Yakovtsova II, Miroshnichenko YM, Chertenko TM. Immunohistochemical features of gastrointestinal stromal tumors and the role of expression of p16ink4A, Ki-67, VEGF and MMP-9 in their behavior. Pathologia. 2021, 18:136-41. 10.14739\/2310-1237.2021.2.233425","journal-title":"Pathologia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1593\/neo.08646","article-title":"p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome","volume":"10","author":"Schmieder M","year":"2008","unstructured":"Schmieder M, Wolf S, Danner B, et al.. p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome. Neoplasia. 2008, 10:1154-62. 10.1593\/neo.08646","journal-title":"Neoplasia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03478.x","article-title":"Expression of p16INK4A in gastrointestinal stromal tumours (GISTs): two different forms exist that independently correlate with poor prognosis","volume":"56","author":"Haller F","year":"2010","unstructured":"Haller F, Agaimy A, Cameron S, et al.. Expression of p16INK4A in gastrointestinal stromal tumours (GISTs): two different forms exist that independently correlate with poor prognosis. Histopathology. 2010, 56:305-18. 10.1111\/j.1365-2559.2010.03478.x","journal-title":"Histopathology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2011.5.2.171","article-title":"Expression of DOG1, PDGFRA, and p16 in gastrointestinal stromal tumors","volume":"5","author":"Jung SH","year":"2011","unstructured":"Jung SH, Suh KS, Kang DY, Kang DW, Kim YB, Kim ES. Expression of DOG1, PDGFRA, and p16 in gastrointestinal stromal tumors. Gut Liver. 2011, 5:171-80. 10.5009\/gnl.2011.5.2.171","journal-title":"Gut Liver"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.638.11.2","article-title":"Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study","volume":"11","author":"Schneider-Stock R","year":"2005","unstructured":"Schneider-Stock R, Boltze C, Lasota J, et al.. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. Clin Cancer Res. 2005, 11:638-45. 10.1158\/1078-0432.638.11.2","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.01.023","article-title":"Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications","volume":"37","author":"Sabah M","year":"2006","unstructured":"Sabah M, Cummins R, Leader M, Kay E. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications. Hum Pathol. 2006, 37:648-55. 10.1016\/j.humpath.2006.01.023","journal-title":"Hum Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193048","article-title":"Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment","volume":"13","author":"Ihle MA","year":"2018","unstructured":"Ihle MA, Huss S, Jeske W, et al.. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment. PLoS One. 2018, 13:e0193048. 10.1371\/journal.pone.0193048","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02071.x","article-title":"The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome","volume":"46","author":"Feakins RM","year":"2005","unstructured":"Feakins RM. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome. Histopathology. 2005, 46:270-9. 10.1111\/j.1365-2559.2005.02071.x","journal-title":"Histopathology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-204","article-title":"P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases","volume":"8","author":"Pauser U","year":"2008","unstructured":"Pauser U, Schmedt Auf der G\u00fcnne N, Kl\u00f6ppel G, Merz H, Feller AC. P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases. BMC Cancer. 2008, 8:204. 10.1186\/1471-2407-8-204","journal-title":"BMC Cancer"},{"key":"ref21","article-title":"Gastrointestinal stromal tumor: a clinical and pathological study of 53 cases","volume":"34","author":"Cai C","year":"2009","unstructured":"Cai C, Meng X, Li J, Xia Y, Zhang G. Gastrointestinal stromal tumor: a clinical and pathological study of 53 cases. J Bengbu Med Univ. 2009, 34:911-3.","journal-title":"J Bengbu Med Univ"},{"key":"ref22","article-title":"Malignant potential of gastrointestinal stromal tumor of the stomach","volume":"94","author":"Aoyagi K","year":"2009","unstructured":"Aoyagi K, Kouhuji K, Yano S, Miyagi M, Imaizumi T, Takeda J, Shirouzu K. Malignant potential of gastrointestinal stromal tumor of the stomach. Int Surg. 2009, 94:1-9.","journal-title":"Int Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0748-7983(03)00073-8","article-title":"Prognostic predictors of gastrointestinal stromal tumors: a multi-institutional analysis of 102 patients with definition of a prognostic index","volume":"29","author":"Kontogianni K","year":"2003","unstructured":"Kontogianni K, Demonakou M, Kavantzas N, et al.. Prognostic predictors of gastrointestinal stromal tumors: a multi-institutional analysis of 102 patients with definition of a prognostic index. Eur J Surg Oncol. 2003, 29:548-56. 10.1016\/s0748-7983(03)00073-8","journal-title":"Eur J Surg Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21781","article-title":"Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate","volume":"106","author":"Steinert DM","year":"2006","unstructured":"Steinert DM, Oyarzo M, Wang X, et al.. Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate. Cancer. 2006, 106:1617-23. 10.1002\/cncr.21781","journal-title":"Cancer"},{"key":"ref25","article-title":"Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas","volume":"4","author":"Kim SH","year":"1998","unstructured":"Kim SH, Lewis JJ, Brennan MF, Woodruff JM, Dudas M, Cordon-Cardo C. Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas. Clin Cancer Res. 1998, 4:2377-82.","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2008.05.007","article-title":"Increased cyclin D3 expression significantly correlates with p27 nuclear positivity in gastrointestinal stromal tumors","volume":"39","author":"Draper N","year":"2008","unstructured":"Draper N, Bui M, Boulware DC, Lloyd M, Chiappori AA, Pledger WJ, Coppola D. Increased cyclin D3 expression significantly correlates with p27 nuclear positivity in gastrointestinal stromal tumors. Hum Pathol. 2008, 39:1784-91. 10.1016\/j.humpath.2008.05.007","journal-title":"Hum Pathol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01665.x","article-title":"Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach","volume":"43","author":"Wong NA","year":"2003","unstructured":"Wong NA, Young R, Malcomson RD, et al.. Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology. 2003, 43:118-26. 10.1046\/j.1365-2559.2003.01665.x","journal-title":"Histopathology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/405499-immunohistochemical-expression-of-p16-p53-bcl2-and-cyclin-d1-in-gastrointestinal-stromal-tumors-correlation-with-clinicopathological-parameters","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:49:40Z","timestamp":1759438180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/405499-immunohistochemical-expression-of-p16-p53-bcl2-and-cyclin-d1-in-gastrointestinal-stromal-tumors-correlation-with-clinicopathological-parameters"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.93731","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,2]]}}}